Association between body mass index and liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver disease in a hepatology clinic: a cross...

por Gopalakrishna, Harish, Fashanu, Oluwaseun E., Nair, Gayatri B., Ravendhran, Natarajan
Publicado 2023

Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study

por Younossi, Zobair M., LaLuna, Louis L., Santoro, John J., Mendes, Flavia, Araya, Victor, Ravendhran, Natarajan, Pedicone, Lisa, Lio, Idania, Nader, Fatema, Hunt, Sharon, Racila, Andrei, Stepanova, Maria
Publicado 2016

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis

por Flamm, Steven, Lawitz, Eric, Borg, Brian, Charlton, Michael, Landis, Charles, Reddy, K. Rajender, Shiffman, Mitchell, Alsina, Angel, Chang, Charissa, Ravendhran, Natarajan, Hernandez, Candido, Hézode, Christophe, Scherbakovsky, Stacey, Mercier, Renee-Claude, Samuel, Didier
Publicado 2023

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis

por Poordad, Fred, Sedghi, Shahriar, Pockros, Paul J., Ravendhran, Natarajan, Reindollar, Robert, Lucey, Michael R., Epstein, Michael, Bank, Leslie, Bernstein, David, Trinh, Roger, Krishnan, Preethi, Polepally, Akshanth R., Unnebrink, Kristina, Martinez, Marisol, Nelson, David R.
Publicado 2019

Safety and efficacy of ledipasvir‐sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data

por Wilder, Julius M., Jeffers, Lennox J., Ravendhran, Natarajan, Shiffman, Mitchell L., Poulos, John, Sulkowski, Mark S., Gitlin, Norman, Workowski, Kimberly, Zhu, Yanni, Yang, Jenny C., Pang, Phillip S., McHutchison, John G., Muir, Andrew J., Howell, Charles, Kowdley, Kris, Afdhal, Nezam, Reddy, K. Rajender
Publicado 2015

All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study

por Nelson, David R, Cooper, James N, Lalezari, Jacob P, Lawitz, Eric, Pockros, Paul J, Gitlin, Norman, Freilich, Bradley F, Younes, Ziad H, Harlan, William, Ghalib, Reem, Oguchi, Godson, Thuluvath, Paul J, Ortiz-Lasanta, Grisell, Rabinovitz, Mordechai, Bernstein, David, Bennett, Michael, Hawkins, Trevor, Ravendhran, Natarajan, Sheikh, Aasim M, Varunok, Peter, Kowdley, Kris V, Hennicken, Delphine, McPhee, Fiona, Rana, Khurram, Hughes, Eric A
Publicado 2015